Table 2.
Gene | Peak of eQTL on LG (cM) | Interval (cM)a | Nearest marker | LOD score | Variance explained (%) | Regulation | Array-eQTLsb | Flowering QTLs |
---|---|---|---|---|---|---|---|---|
FLC1_A10.RL | (A09) 128.2 | 123.4–129.2 | P14m51m321.6 | 4.3 | 18.6 | trans | ND | – |
(A10) 83.6 | 78.2–94.2 | BRH80A08flc1 (DA10) | 3.1 | 12.8 | cis | A10 | – | |
FLC2_A02.RL | (A02) 24.1 | 22.5–27.2 | BRH04D11flc2 (DXA02) | 24.6 | 71.4 | cis | ND | A02 |
FLC3_A03.RL | (A03) 29.2 | 23.4–34.5 | E37M47M128.1 | 4.9 | 22.7 | cis | A03 | – |
FLC5_A03.RL | (A05) 54.9 | 51.1–58.9 | BrFES1P3b (XSA05) | 3.7 | 17.9 | trans | A03 | – |
FT_A07(1).RL | (A02) 21.1 | 17.6–23.3 | BrFLC2-2 (XSA02) | 6.5 | 24.0 | trans | ND | – |
FT_A07(2).RL | (A02) 21.1 | 17.6–23.3 | BrFLC2-2 (XSA02) | 3.4 | 16.5 | trans | ND | – |
(A05) 81.9 | 80.5–86.0 | P14M51M121.9 | 3.0 | 12.3 | trans | ND | – | |
SOC1_A03.RL | (A02) 48.3 | 46.7–49.9 | BrPIP1b(XSA02) | 4.7 | 17.9 | trans | ND | – |
(A09) 128.2 | 116.9–129.2 | P14M51M321.6 | 3.6 | 13.5 | trans | ND | – | |
SOC1_A05.RL | (A02) 36.9 | 27.2–42.9 | ENA13I (DA02) | 4.1 | 16.4 | trans | ND | - |
CO_A10.RL | (A02) 21.5 | 16.3–29.8 | BrFLMP2d (XSA02) | 3.4 | 10.7 | trans | ND | A02 |
(A05) 19.2 | 5.0–28.1 | BrSPA1P1a (XXA05) | 4.2 | 13.6 | trans | ND | – | |
(A10) 76.2 | 64.2–82.2 | BrCOL1P1c (XSA10) | 4.9 | 16.1 | cis | ND | – | |
CCA1_A05.RL | (A05) 23.1 | 22.2–32.1 | BrSPA1P2a (XSA05) | 22.1 | 69.0 | cis | ND | – |
ARR3_A09.RL | (A09) 66.5 | 65.6–68.9 | E32M47M56.0 | 16.7 | 58.7 | cis | A09 | – |
FRL2_A09.RL | (A09) 74.3 | 74.0–74.8 | BrCRY1P2d (XXA09) | 30.4 | 80.0 | cis | A09 | – |
CAM1_A07.RL | (A07) 0.0 | 0.0–5.0 | BrAP3P1b (XSA07) | 3.0 | 14.6 | cis | A07 | – |
a1.0 LOD confidence interval.
b ND indicates that the gene was not represented on the Cogenics Microarray.